March 10 (Reuters) - Mylan NV: * MYLAN PHARMACEUTICALS ULC LAUNCHES WIXELA® INHUB® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP), THE FIRST AVAILABLE BIOEQUIVALENT ALTERNATIVE TO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback